Jose I Suarez

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi request reprint Effect of human albumin on TCD vasospasm, DCI, and cerebral infarction in subarachnoid hemorrhage: the ALISAH study
    Jose I Suarez
    Division of Vascular Neurology and Neurocritical Care, Baylor College of Medicine, Baylor St Luke s Medical Center, 6501 Fannin St, NB 302, Houston, TX, 77030, USA
    Acta Neurochir Suppl 120:287-90. 2015
  2. pmc The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes
    Jose I Suarez
    Department of Neurology, Baylor College of Medicine, 6501 Fannin Street, NB 302, Houston, TX 77030, USA
    Stroke 43:683-90. 2012
  3. ncbi request reprint The neurocritical care research network: NCRN
    J I Suarez
    Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
    Neurocrit Care 16:29-34. 2012
  4. ncbi request reprint Magnesium sulfate administration in subarachnoid hemorrhage
    Jose I Suarez
    Department of Neurology, Baylor College of Medicine, 6501 Fannin St, NB302, Houston, TX 77030, USA
    Neurocrit Care 15:302-7. 2011
  5. ncbi request reprint Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design
    Jose I Suarez
    Department of Neurology, Divisions Vascular Neurology and Neurocritical Care, Baylor College of Medicine, 6501 Fannin St, MS NB320, Houston, TX 77030, USA
    Neurocrit Care 13:263-77. 2010
  6. ncbi request reprint Impact of a specialized neurointensive care team on outcomes of critically ill acute ischemic stroke patients
    Eric M Bershad
    Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, One Baylor Plaza, NB 302, Houston, TX 77030, USA
    Neurocrit Care 9:287-92. 2008
  7. ncbi request reprint Clinical trial design in the neurocritical care unit
    C E Hall
    University of Texas Southwestern, Dallas, TX, USA
    Neurocrit Care 16:6-19. 2012
  8. ncbi request reprint Thrombolysis for acute ischemic stroke in patients with cancer: a population study
    Santosh B Murthy
    From the Department of Neurology, Baylor College of Medicine, Houston, TX S B M, S S, C P V R, E M B, J I S Division of Management, Policy and Community Health, University of Texas School of Public Health, Houston, TX S K and Department of Hematology and Oncology, Montefiore Medical Center, Bronx, NY A S
    Stroke 44:3573-6. 2013
  9. ncbi request reprint The SILK flow diverter in the treatment of intracranial aneurysms
    Santosh B Murthy
    Department of Neurology, Baylor College of Medicine, 6501 Fannin, NB 302, Houston, TX 77030, USA Electronic address
    J Clin Neurosci 21:203-6. 2014
  10. ncbi request reprint Comparing multislice electrocardiogram-gated spiral computerized tomography and transesophageal echocardiography in evaluating aortic atheroma in patients with acute ischemic stroke
    Syed I Hussain
    Department of Neurology, Medical College of Wisconsin Froedtert Hospital, Milwaukee, Wisconsin 55326, USA
    J Stroke Cerebrovasc Dis 17:134-40. 2008

Collaborators

Detail Information

Publications25

  1. ncbi request reprint Effect of human albumin on TCD vasospasm, DCI, and cerebral infarction in subarachnoid hemorrhage: the ALISAH study
    Jose I Suarez
    Division of Vascular Neurology and Neurocritical Care, Baylor College of Medicine, Baylor St Luke s Medical Center, 6501 Fannin St, NB 302, Houston, TX, 77030, USA
    Acta Neurochir Suppl 120:287-90. 2015
    ..We investigated the effect of 25 % human albumin (ALB) on mean cerebral blood flow velocities (MCBFV), delayed cerebral ischemia (DCI), and cerebral infarction...
  2. pmc The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes
    Jose I Suarez
    Department of Neurology, Baylor College of Medicine, 6501 Fannin Street, NB 302, Houston, TX 77030, USA
    Stroke 43:683-90. 2012
    ..We investigated the safety and tolerability of 25% human albumin in patients with subarachnoid hemorrhage...
  3. ncbi request reprint The neurocritical care research network: NCRN
    J I Suarez
    Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
    Neurocrit Care 16:29-34. 2012
    ..The mission of the Network is to facilitate multicenter and multidisciplinary collaboration and patient enrollment in clinical trials of specific neurocritical care diseases...
  4. ncbi request reprint Magnesium sulfate administration in subarachnoid hemorrhage
    Jose I Suarez
    Department of Neurology, Baylor College of Medicine, 6501 Fannin St, NB302, Houston, TX 77030, USA
    Neurocrit Care 15:302-7. 2011
    ..Benefit was likewise not supported in the single phase III clinical trial...
  5. ncbi request reprint Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design
    Jose I Suarez
    Department of Neurology, Divisions Vascular Neurology and Neurocritical Care, Baylor College of Medicine, 6501 Fannin St, MS NB320, Houston, TX 77030, USA
    Neurocrit Care 13:263-77. 2010
    ..The Glasgow Outcome Scale, Barthel Index, modified Rankin Scale, NIH Stroke Scale, and Stroke Impact Scale will be performed 3 months after the onset of symptoms to assess residual neurological deficits...
  6. ncbi request reprint Impact of a specialized neurointensive care team on outcomes of critically ill acute ischemic stroke patients
    Eric M Bershad
    Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, One Baylor Plaza, NB 302, Houston, TX 77030, USA
    Neurocrit Care 9:287-92. 2008
    ..This study is intended to investigate such benefit...
  7. ncbi request reprint Clinical trial design in the neurocritical care unit
    C E Hall
    University of Texas Southwestern, Dallas, TX, USA
    Neurocrit Care 16:6-19. 2012
    ..In this manuscript, five invited experts were impaneled to address questions, identified by the conference organizing committee as fundamental issues for the design of clinical trials in the neurological intensive care unit setting...
  8. ncbi request reprint Thrombolysis for acute ischemic stroke in patients with cancer: a population study
    Santosh B Murthy
    From the Department of Neurology, Baylor College of Medicine, Houston, TX S B M, S S, C P V R, E M B, J I S Division of Management, Policy and Community Health, University of Texas School of Public Health, Houston, TX S K and Department of Hematology and Oncology, Montefiore Medical Center, Bronx, NY A S
    Stroke 44:3573-6. 2013
    ..The safety of thrombolysis for acute stroke in patients with cancer is not well established. Our aim is to study the outcomes after thrombolysis in patients with stroke with cancer...
  9. ncbi request reprint The SILK flow diverter in the treatment of intracranial aneurysms
    Santosh B Murthy
    Department of Neurology, Baylor College of Medicine, 6501 Fannin, NB 302, Houston, TX 77030, USA Electronic address
    J Clin Neurosci 21:203-6. 2014
    ....
  10. ncbi request reprint Comparing multislice electrocardiogram-gated spiral computerized tomography and transesophageal echocardiography in evaluating aortic atheroma in patients with acute ischemic stroke
    Syed I Hussain
    Department of Neurology, Medical College of Wisconsin Froedtert Hospital, Milwaukee, Wisconsin 55326, USA
    J Stroke Cerebrovasc Dis 17:134-40. 2008
    ..The aim of this study was to compare transesophageal echocardiography (TEE) and cardiac-gated computerized tomography (CGCT) in detecting aortic atherosclerosis (AA)...
  11. ncbi request reprint Clinical characteristics of myocardial stunning in acute stroke
    Santosh B Murthy
    Department of Neurology, Baylor College of Medicine, 6501 Fannin, NB 302, Houston, TX 77030, USA
    J Clin Neurosci 21:1279-82. 2014
    ..While the lack of prospective studies on NSM in stroke patients precludes drawing further conclusions, more studies are warranted to investigate the risk factors for NSM and the effect on stroke outcomes...
  12. ncbi request reprint Human albumin administration in subarachnoid hemorrhage: results of an international survey
    Jose I Suarez
    Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, 1 Baylor Plaza, NB 320, Houston, TX, 77030, USA
    Neurocrit Care 20:277-86. 2014
    ..However, current usage of ALB in SAH is not known. We conducted an international survey of clinicians involved in the care of SAH patients to determine current practice of ALB administration in SAH...
  13. pmc Stroke severity predicted by aortic atheroma detected by ultra-fast and cardiac-gated chest tomography
    Marc A Lazzaro
    Department of Neurology, Medical College of Wisconsin Froedtert Hospital Milwaukee, WI, USA
    Front Neurol 2:18. 2011
    ..There was no evidence of association with 3-month functional outcome using the mRS...
  14. ncbi request reprint Marked olfactory impairment in idiopathic intracranial hypertension
    Eric M Bershad
    Department of Neurology, Baylor College of Medicine, Houston, Texas, USA
    J Neurol Neurosurg Psychiatry 85:959-64. 2014
    ..We prospectively evaluated olfactory function in IIH patients and the effect of 6° head-down tilt, which simulates the headward fluid shifting in microgravity, as spaceflight analogues...
  15. ncbi request reprint Stroke-associated pneumonia: major advances and obstacles
    Yousef Hannawi
    Department of Neurology, Baylor College of Medicine, Houston, TX, USA yousefhannawi yahoo com
    Cerebrovasc Dis 35:430-43. 2013
    ..We reviewed the pathophysiology, microbiology, incidence, risk factors, outcomes and prophylaxis of SAP with special attention to ICU studies...
  16. ncbi request reprint Treatment of unruptured intracranial aneurysms with the pipeline embolization device
    Santosh B Murthy
    Department of Neurology, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA
    J Clin Neurosci 21:6-11. 2014
    ..More prospective clinical trials are warranted to further validate these results...
  17. ncbi request reprint Hypertonic saline for cerebral edema
    Alexandros L Georgiadis
    Department of Neurology, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106, USA
    Curr Neurol Neurosci Rep 3:524-30. 2003
    ..However, hypertonic saline solutions have recently emerged as a potentially safer and more efficacious alternative to mannitol...
  18. ncbi request reprint Intracranial hypertension
    Eric M Bershad
    Department of Neurology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    Semin Neurol 28:690-702. 2008
    ..Several integrated management paradigms have been used to treat intracranial hypertension. Regrettably, there is a dearth of randomized clinical trials to confirm the efficacy of even our most routine therapeutic strategies...
  19. ncbi request reprint Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature
    Eric M Bershad
    Baylor College of Medicine, Houston, TX, USA
    Neurocrit Care 12:403-13. 2010
    ..PCC has features which make it a promising therapy for patients with warfarin-related intracranial hemorrhage, and deserves more rigorous study in prospective-randomized controlled trials...
  20. ncbi request reprint Breathing and the nervous system
    Mian Zain Urfy
    Department of Neurology, Baylor College of Medicine, Houston, TX, USA
    Handb Clin Neurol 119:241-50. 2014
    ..Clinicians should have a better understanding of this complex but important physiological process to better appreciate pathologies affecting it. Future research is needed to enhance our understanding of this intricate process. ..
  21. ncbi request reprint Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity
    Eroboghene E Ubogu
    Department of Neurology, University Hospitals of Cleveland, Hanna House 5th Floor, 11100 Euclid Avenue, Cleveland, OH 44106 5040, USA
    Epilepsy Behav 4:70-5. 2003
    ..Animal studies of prolonged ketamine therapy are required before widespread human use in SE...
  22. ncbi request reprint Coagulopathy and inhospital deaths in patients with acute subdural hematoma
    Eric M Bershad
    Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA
    J Neurosurg 109:664-9. 2008
    ..The authors sought to determine if such a relationship exists for patients with acute SDH...
  23. ncbi request reprint Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations
    Adnan I Qureshi
    Zeenat Qureshi Stroke Research Center, Department of Neurology, University of Minnesota, Minneapolis, Minnesota 55455, USA
    J Neuroimaging 22:1-13. 2012
    ..The purpose of this report is to review the components of the designs and methods SAMMPRIS trial and to describe the influence of those components on the interpretation of trial results...
  24. pmc Therapeutic hypothermia in stroke and traumatic brain injury
    Alireza Faridar
    Department of Neurology, University of Minnesota Minneapolis, MN, USA
    Front Neurol 2:80. 2011
    ..It is very likely that combining neuroprotective strategies will yield better outcomes than utilizing a single approach...
  25. ncbi request reprint Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke
    Thomas Wolfe
    Department of Neurology, Medical College of Wisconsin Froedtert Hospital, Milwaukee, Wisconsin 53226, USA
    J Stroke Cerebrovasc Dis 17:121-8. 2008
    ..We sought to compare the safety and efficacy of combined intravenous (IV) and intra-arterial (IA) thrombolysis with primary IA therapy using tissue plasminogen activator for acute ischemic stroke presenting within 6 hours of symptom onset...